Halozyme Therapeutics
HALO
#2187
Rank
S$9.62 B
Marketcap
$75.63
Share price
2.08%
Change (1 day)
65.91%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): S$0.63 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are S$0.94 Billion. In 2023 the company made an earning of S$0.47 Billion, an increase over its 2022 earnings that were of S$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.63 B34.7%
2023 S$0.47 B39.94%
2022 S$0.33 B0.16%
2021 S$0.33 B92.2%
2020 S$0.17 B-278.96%
2019 -S$97.69 Million-9.45%
2018 -S$0.11 Billion-229.51%
2017 S$83.29 M-160.48%
2016 -S$0.14 Billion216.03%
2015 -S$43.58 Million-52.86%
2014 -S$92.45 Million-18.09%
2013 -S$0.12 Billion55.88%
2012 -S$72.41 Million169.94%
2011 -S$26.83 Million-63.44%
2010 -S$73.36 Million-7.19%
2009 -S$79.04 Million15.91%
2008 -S$68.19 Million83.89%
2007 -S$37.09 Million78.1%
2006 -S$20.83 Million16%
2005 -S$17.95 Million45.24%
2004 -S$12.36 Million682.42%
2003 -S$1.58 Million1659.12%
2002 -S$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$33.84 M-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.72 B 2,014.28%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.22 B-65.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.38 B 1,346.18%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.01 B 1,443.00%๐Ÿ‡ซ๐Ÿ‡ท France
S$24.87 B 3,731.55%๐Ÿ‡บ๐Ÿ‡ธ USA